ArticleRespiratory medicine case reports2026
Internal auditory canal metastasis as the only brain lesion in progressive lung adenocarcinoma: Case report and literature review.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metastases to the internal auditory canal (IAC) are exceptionally rare, especially as a solitary lesion without associated parenchymal brain or leptomeningeal involvement. Lung adenocarcinomas with a signet-ring cell component are aggressive and prone to early dissemination. Case presentation: We report a 64-year-old man with stage IV lung adenocarcinoma with a signet-ring cell component who developed rapidly progressive left-sided facial palsy, vertigo, and hearing loss. Brain MRI revealed a solitary enhancing lesion in the left IAC. Considering the clinical context and rapid symptom progression, a metastatic lesion was suspected. The patient was treated with corticosteroids and radiotherapy. At three-week follow-up, he showed marked improvement in vertigo and hearing, with partial recovery of facial nerve function (House-Brackmann grade III). Conclusion: This case highlights the importance of recognizing rare sites of metastasis in patients with known malignancy. Early diagnosis and prompt treatment with a multidisciplinary approach can lead to meaningful neurological improvement and symptom relief, even in the context of ongoing systemic disease. Clinicians should be alert for IAC metastases when acute cochleovestibular or facial nerve symptoms occur.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.